AJR AJR-based Continuing Ed for Technologists
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamagami, T.
Right arrow Articles by Nishimura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamagami, T.
Right arrow Articles by Nishimura, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2002; 179:1611-1617
© American Roentgen Ray Society


Using n-Butyl Cyanoacrylate and the Fixed-Catheter-Tip Technique in Percutaneous Implantation of a Port-Catheter System in Patients Undergoing Repeated Hepatic Arterial Chemotherapy

Takuji Yamagami1, Shigeharu Iida, Takeharu Kato, Osamu Tanaka, Tatsuya Hirota, Toshiyuki Nakamura and Tsunehiko Nishimura

1 All authors: Department of Radiology, Kyoto Prefectural University of Medicine, 465 Kajii-chyo, Kawaramachi-Hirokoji, Kamigyo, Kyoto, 602-0841, Japan.

Received February 11, 2002; accepted after revision June 6, 2002.

 
Address correspondence to T. Yamagami.


Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
OBJECTIVE. The purpose of our study was to evaluate the usefulness of adding n-butyl cyanoacrylate to microcoils to fix the catheter tip in percutaneous implantation of a port-catheter system for hepatic arterial—infusion chemotherapy.

SUBJECTS AND METHODS. Ninety-three patients (64 men and 29 women; age range, 38-83 years; mean age, 62.2 years) with unresectable advanced liver cancer underwent percutaneous implantation of a port-catheter system with the catheter tip fixed at the gastroduodenal artery with microcoils and a mixture of n-butyl cyanoacrylate and iodized oil. The rates of successful implantation and complications closely associated with this technique and management of the complications were reviewed.

RESULTS. Percutaneous port-catheter placement was successfully performed in all patients. However, in eight patients, complications occurred: hepatic arterial obstruction (n = 5, 5.4%); catheter dislocation (n = 2, 2.2%); recanalization of the gastroduodenal artery (n = 1, 1.1%); or movement of n-butyl cyanoacrylate (n = 1, 1.1%). In five of the eight patients with complications, hepatic arterial—infusion chemotherapy was continued either after observation of the patient to ensure that stability had been established or after treatment using comparatively easy interventional techniques. In three (3.2%) of the 93 patients, planned hepatic arterial—infusion chemotherapy could not be performed because of complications associated with the technique.

CONCLUSION. Fixation of the catheter tip in the gastroduodenal artery using a combination of microcoils and a mixture of n-butyl cyanoacrylate and iodized oil is a useful and safe technique in percutaneous port-catheter placement for repeated hepatic arterial infusion chemotherapy.


Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Repeated hepatic arterial—infusion chemotherapy via an implanted port-catheter system is widely known as a last-resort treatment for unresectable advanced liver cancer [1, 2]. In the past, the placement of the port-catheter system was an invasive procedure, requiring surgical laparotomy with the patient under general anesthesia [3,4,5,6]. However, recent advancements in interventional techniques have made it possible to implant a port-catheter system percutaneously with the patient under local anesthesia [7,8,9,10,11,12,13,14,15].

Among the various interventional techniques [7,8,9,10,11,12,13,14,15], fixed-catheter-tip implantation [7, 8] is particularly advantageous, especially for preventing catheter dislocation. In this technique, a side hole is made in the indwelling catheter at site of the common hepatic artery ostium. The end hole of the catheter is then closed with a microcoil. The tip of the indwelling catheter is fixed to the gas-troduodenal artery with microcoils via a microcatheter, which is introduced into the gastroduodenal artery through the side hole of the indwelling catheter.

However, catheter dislocation has occurred in some patients. Through trial and error, we noticed (as described in our previous report [8]) that fixing the catheter tip with n-butyl cyanoacrylate resulted in fewer catheter dislocations than did fixation with microcoils alone. However, large studies using n-butyl cyanoacrylate in percutaneous catheter placement have been rare [8]. The aim of our article is to describe the efficacy of and results achieved by adding n-butyl cyanoacrylate to microcoils during fixation of the catheter tip to the gastroduodenal artery.


Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Patients
Between April 1998 and September 2001, 93 patients (64 men and 29 women; age range, 38-83 years; mean age, 62.2 years) with unresectable advanced liver cancer underwent placement of a percutaneously implantable port-catheter system with the catheter tip fixed at the gastroduodenal artery by embolic agents applied to the outside of the catheter. Of the 93 patients, 35 had primary liver cancer and 58 had metastatic liver cancer that originated from colorectal (n = 24), breast (n = 17), gastric (n = 8), lung (n = 3), gallbladder (n = 2), pancreatic (n = 1), ovarian (n = 1), anal (n = 1), or jejunal cancer (n = 1). All patients had diffuse or multiple (more than five) malignant lesions or a few huge malignant lesions in both the right and left lobes of the liver, making surgical resection impossible. Most of these patients had received systemic chemotherapy or other interventional treatments, only to develop intractable disease.

Procedures
After obtaining written informed consent from the patients, we percutaneously placed a long-term indwelling catheter for frequent arterial infusion chemotherapy, according to the procedure described by Arai et al. [7] (Fig. 1A,1B,1C,1D,1E,1F,1G,1H). First, a 5-French catheter (Clinical Supply, Gifu, Japan) was inserted via a branch of the left subclavian artery or of the right femoral artery—both of which were exposed by minimally invasive surgery after the skin incision was made with the patients under local anesthesia—and was advanced to the common hepatic artery via the celiac artery (Fig. 1A). In most cases, we used the cutdown technique to insert the catheter from the arterial branch. Next, a microcatheter (Renegade-18; Boston Scientific, Watertown, MA) was inserted coaxially, after which branches of the gastroduodenal artery, such as the posterosuperior pancreaticoduodenal artery, were embolized with microcoils (Diamond Coil, Boston Scientific; or Trufill, Cordis, Miami, FL) to prevent infusion of chemotherapeutic agents into the duodenum and pancreas if these branches arose near the bifurcation.



View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A. 62-year-old man with liver metastasis from colon cancer in whom port-catheter system was placed using fixed-catheter-tip technique with addition of n-butyl cyanoacrylate. Arteriogram shows 5-French catheter inserted from left subclavian artery being advanced to common hepatic artery. Microcoils (arrow) that were inserted in right gastric artery before placement of indwelling catheter are visible.

 


View larger version (159K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B. 62-year-old man with liver metastasis from colon cancer in whom port-catheter system was placed using fixed-catheter-tip technique with addition of n-butyl cyanoacrylate. Radiograph shows indwelling catheter (short thick arrow) with side hole being advancing over microguidewire already positioned with its tip in right gastroepiploic artery (long arrow). Microcoil (short thin arrow) is used to embolize branch of gastroduodenal artery arising near bifurcation.

 


View larger version (141K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C. 62-year-old man with liver metastasis from colon cancer in whom port-catheter system was placed using fixed-catheter-tip technique with addition of n-butyl cyanoacrylate. Arteriogram obtained immediately after advancement of side hole of indwelling catheter to planned position confirms that side hole opens to common hepatic artery (arrow) and that all intrahepatic arterial branches are visualized.

 


View larger version (165K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1D. 62-year-old man with liver metastasis from colon cancer in whom port-catheter system was placed using fixed-catheter-tip technique with addition of n-butyl cyanoacrylate. Radiograph shows that distal lumen of indwelling catheter beyond side hole is occluded, with microcoil (thick arrow) inserted through microcatheter advanced inside indwelling catheter. Marker (thin arrow) on tip of microcatheter is also visualized.

 


View larger version (155K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1E. 62-year-old man with liver metastasis from colon cancer in whom port-catheter system was placed using fixed-catheter-tip technique with addition of n-butyl cyanoacrylate. Radiograph shows microcatheter has been inserted coaxially through side hole (thick arrow) of indwelling catheter to gastroduodenal artery outside indwelling catheter over micro-guidewire that already has been advanced to gastroduodenal artery (thin arrow).

 


View larger version (148K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1F. 62-year-old man with liver metastasis from colon cancer in whom port-catheter system was placed using fixed-catheter-tip technique with addition of n-butyl cyanoacrylate. Radiograph shows that tip of indwelling catheter is fixed to gastroduodenal artery with microcoils (thick arrow) and mixture of n-butyl cyanoacrylate and iodized oil (thin arrow).

 


View larger version (143K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1G. 62-year-old man with liver metastasis from colon cancer in whom port-catheter system was placed using fixed-catheter-tip technique with addition of n-butyl cyanoacrylate. Radiograph shows proximal end of indwelling catheter connected to port implanted subcutaneously.

 


View larger version (135K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1H. 62-year-old man with liver metastasis from colon cancer in whom port-catheter system was placed using fixed-catheter-tip technique with addition of n-butyl cyanoacrylate. Arteriogram via port obtained after placement of port-catheter system confirms that all hepatic arterial branches are well visualized and that inside lumen of catheter tip is occluded. Note that catheter tip is fixed in gastroduodenal artery.

 

Using the catheter-exchange method, an indwelling catheter with a side hole was placed with the tip inserted into the gastroduodenal artery (Fig. 1B). The side hole was placed into the common hepatic artery (Fig. 1C). The distal lumen of the indwelling catheter then was occluded with a 1.2-cm microcoil (Hilal embolization microcoils; Cook Europe, Bjaeverskov, Denmark) through a coaxial microcatheter (Renegade-18; Boston Scientific) that was advanced beyond the side hole inside the indwelling catheter (Fig. 1D).

The gastroduodenal artery was embolized with microcoils (Diamond Coil, Boston Scientific or Trufill, Cordis) through a microcatheter inserted coaxially via the side hole of the indwelling catheter into the gastroduodenal artery outside the catheter (Fig. 1E and 1F). In all patients, 0.5-1.25 mL of n-butyl cyanoacrylate (Histoacryl-Blue; Braun, Melsungen, Germany) mixed with iodized oil (Lipiodol; Laboratoire Guerbet, Roissy, France) was added for sufficient embolization and to fix the catheter tip more securely (Fig. 1F). The ratio of n-butyl cyanoacrylate to iodized oil was 1:1.5. Finally, the proximal end of the indwelling catheter was connected to a port (Septum port, Sumitomo Bakelite, Akita, Japan; or PU Celsite Port, Toray Medical, Tokyo, Japan) implanted subcuntaneously (Fig. 1G).

A polyurethane-covered catheter (Anthron PU catheter; Toray Medical) with a tapered tip (outer diameter of the shaft, 5 French and that of the tip, 2.7 French; inner diameter of the shaft, 0.035 inch and that of the tip, 0.018 inch) was used as the indwelling catheter, and a side hole was created at the point at which the diameter tapered by clipping the folded indwelling catheter with a pair of small scissors. The length between the side hole and the distal end of the indwelling catheter was designed according to the findings of a previously obtained celiac arteriogram. The redundant distal part of the catheter tip was cut off.

In 80 of the 93 patients, the right gastric artery was embolized with microcoils to prevent infusion of chemotherapeutic agents into the stomach. The embolization was performed as the first step in the port-catheter implantation procedure or as a preparatory procedure on the day before port-catheter implantation. In four of these patients, embolization was unsuccessful. Gastrectomy had been performed previously in the remaining 13 patients (gastric cancer, n = 8; gastric ulcer, n = 5), and the right gastric artery had been ligated at the time of surgery.

In patients with more than two hepatic arteries, the arteries were converted into one hepatic artery. In patients in whom this conversion was accomplished, infusion of the entire liver could be undertaken with a single indwelling catheter. To convert multiple hepatic arteries into one, we embolized all of the hepatic arteries with the exception of the hepatic artery from which the gastroduodenal artery diverged.

All patients were examined with digital subtraction angiography (Fig. 1H) and single-detector helical CT after infusion of contrast material via the port to confirm the patency of the hepatic artery and good distribution of the contrast material to the entire liver and to rule out the possibility of extrahepatic infusion. These studies were done 5-10 days after implantation and every 1-3 months thereafter.

Parameters Investigated
We investigated the rate of success of the fixed-catheter-tip technique of port-catheter placement using the mixture of n-butyl cyanoacrylate and iodized oil and the rate of complications closely associated with this technique. Management was examined in patients with complications.


Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
As of December 2001, 19 of the 93 patients had died; the survival period after port-catheter system placement ranged from 2 to 30 months (mean, 9 months). The 74 surviving patients were followed up for a period ranging from 3 to 41 months (mean, 17.6 months) after the catheter placement.

In all patients, all branches of the hepatic arteries beyond the proper hepatic artery were well visualized. Branches of the gastroduodenal artery were not evident on arteriography that was performed after the infusion of contrast material via the port just after placement of the indwelling port-catheter system. Thus, the success of implantation was confirmed.

However, as Table 1 shows, eight patients experienced some complications that were closely associated with the technique under study. Hepatic arterial obstruction was seen on follow-up arteriography performed via the port in five (5.4%) of 93 patients (Fig. 2A,2B). In two, the right hepatic artery was obstructed, and in one, the left hepatic artery. In the remaining two, no hepatic arterial branches beyond the point of divergence of the gastroduodenal artery were visualized. The hepatic artery was successfully recanalized by infusing thrombolytics via the port in one patient found to have right hepatic arterial obstruction 7 days after catheter placement and in a patient found to have obstruction of the proper hepatic artery 28 days after catheter placement. However, attempts to treat the hepatic arterial occlusions in the remaining three patients using various thrombolytic methods failed. In the patient with obstruction of the left hepatic artery, tumors were mainly located in the right lobe; thus, repeated hepatic arterial—infusion chemotherapy via the port-catheter system was continued. In the other two patients, further hepatic arterial chemotherapy via the indwelling catheter was not attempted.


View this table:
[in this window]
[in a new window]

 
TABLE 1 Complications Arising After Percutaneous Placement of a Port-Catheter System Using Catheter-Tip-Fixation Technique and n-Butyl Cyanoacrylate Among 93 Patients Treated with Hepatic Arterial Infusion Chemotherapy

 


View larger version (112K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A. 67-year-old woman with hepatocellular carcinoma who developed hepatic arterial occlusion. Arteriogram via port obtained 28 days after implantation of port-catheter system shows obstruction of proper hepatic artery. Microcoils (small arrows) and cast of n-butyl cyanoacrylate and iodized oil mixture (thick arrow) to fix catheter tip as well as microcoils to embolize right gastric artery (thin arrows) can be seen.

 


View larger version (119K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B. 67-year-old woman with hepatocellular carcinoma who developed hepatic arterial occlusion. After 1 day of continuous transarterial infusion of 120,000 U of urokinase via port, arteriogram via port shows recanalization of hepatic artery.

 

In two patients (2.2%), catheter dislocation (Fig. 3A,3B) was confirmed, one 77 days after catheter placement and the other 283 days after placement. In both patients, the catheter moved proximally to the direction of the celiac artery, and the side hole moved to the celiac axis. Distribution of chemotherapeutic agents to the left gastric artery or to the splenic artery can damage adjacent organs such as the stomach or pancreas, so further hepatic arterial chemotherapy was not attempted. In the patient with the right hepatic arterial obstruction and a dislocated catheter, tumors were mainly located in the right lobe of the liver, which was another reason we abandoned attempts at further hepatic arterial infusion chemotherapy.



View larger version (147K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A. 65-year-old man with liver metastasis from colon cancer and migration of catheter tip. Arteriogram via port obtained just after implantation shows that port-catheter system is correctly positioned. Microcoils were inserted into right hepatic artery that arose from superior mesenteric artery to convert two hepatic arteries into one (thin arrows). Distal lumen of indwelling catheter is occluded with microcoil (thick arrow).

 


View larger version (147K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B. 65-year-old man with liver metastasis from colon cancer and migration of catheter tip. Arteriogram via port obtained 283 days after implantation of port-catheter system shows catheter-tip dislocation and movement of side hole to more proximal site, resulting in visualization of left gastric artery (thick arrow) and splenic artery (thin arrow).

 

In one patient (1.1%), recanalization of the gastroduodenal artery was revealed on arteriography performed via the port 5 days after the port-catheter implantation (Fig. 4A,4B,4C). Later, successful reembolization was accomplished using a mixture of n-butyl cyanoacrylate and iodized oil. The mixture was delivered via a microcatheter advanced through the 5-French catheter in the celiac artery.



View larger version (153K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4A. 69-year-old woman with liver metastasis from breast cancer and recanalization of gastroduodenal artery. Arteriogram via port obtained 5 days after implantation of port-catheter system shows that gastroduodenal artery is recanalized (thick arrow), although this artery was embolized with microcoils and mixture of n-butyl cyanoacrylate and iodized oil at time of catheter placement. Note microcoils embolizing right gastric artery (thin arrow).

 


View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4B. 69-year-old woman with liver metastasis from breast cancer and recanalization of gastroduodenal artery. Arteriogram shows recanalization of gastroduodenal artery. Microcatheter was coaxially advanced through common hepatic artery to gastroduodenal artery outside of indwelling catheter via 5-French catheter inserted from right femoral artery and positioned at celiac artery.

 


View larger version (145K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4C. 69-year-old woman with liver metastasis from breast cancer and recanalization of gastroduodenal artery. Arteriogram via port obtained after procedure to correct recanalization of gastroduodenal artery shows gastroduodenal artery (arrow) successfully reembolized outside of indwelling catheter with n-butyl cyanoacrylate and iodized oil mixture.

 

Migration of the cast of the n-butyl cyanoacrylate and iodized oil mixture to the proper hepatic artery during the procedure occurred in one patient (1.1%). The arteriography via the port showed that the cast had moved into the right hepatic artery 5 days after catheter implantation (Fig. 5A,5B,5C). Although mild stenosis of the right hepatic artery occurred because of this episode, hepatopetal arterial blood flow was sufficient; thus, hepatic arterial—infusion chemotherapy was performed with no need for corrective therapy. Catheter occlusion did not occur in any of the patients.



View larger version (148K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5A. 47-year-old woman with liver metastasis from breast cancer and migration of n-butyl cyanoacrylate plug. Arteriogram via port obtained just after implantation shows port-catheter system is correctly positioned but cast (arrow) of mixture of n-butyl cyanoacrylate and iodized oil has migrated into proper hepatic artery.

 


View larger version (139K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5B. 47-year-old woman with liver metastasis from breast cancer and migration of n-butyl cyanoacrylate plug. Arteriogram via port obtained 5 days after implantation of port-catheter system shows that cast (arrow) of n-butyl cyanoacrylate and iodized oil mixture has moved to right hepatic artery. Nevertheless, blood flow of right hepatic artery was sufficient.

 


View larger version (145K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5C. 47-year-old woman with liver metastasis from breast cancer and migration of n-butyl cyanoacrylate plug. CT scan obtained during arteriography via port reveals that contrast material is being distributed to entire liver but not to adjacent extrahepatic organs such as pancreas and stomach wall. Sufficient distribution of contrast material to tumor lesion (arrow) is also seen.

 

We evaluated other complications unrelated to the technique of fixing the catheter tip with n-butyl cyanoacrylate and iodized oil. In two patients, brain infarction was shown on brain CT or MR imaging to be located mainly in the posterior arterial territory. We strongly suspected this complication was related to catheter placement via the left subclavian artery in both patients. Clinical symptoms occurred 8 days after port-catheter placement in one of these patients and 211 days after the procedure in the other patient. Conservative treatment that included the use of anticoagulant medication was effective. All other complications caused directly by percutaneous implantation of the port-catheter system were minor, such as transient subcutaneous hematoma.


Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Repeated hepatic arterial infusion chemotherapy is the treatment of choice for unresectable advanced liver cancer in patients for whom systemic chemotherapy or other interventional therapies are not effective [1, 2]. In the past, anticancer drugs were infused via a catheter with its tip at the hepatic artery; the catheter was inserted via the gastroduodenal artery exposed at surgical laparotomy with the patient under general anesthesia [3,4,5,6]. However, the recent development of interventional techniques has made it possible to implant port-catheter systems percutaneously with the patient under local anesthesia [7,8,9,10,11,12,13,14,15].

A review of large published studies [9,10,11,12,13,14] found more than 30 procedures of percutaneous port-catheter placement described for hepatic arterial—infusion chemotherapy, with the most common interventional procedure involving positioning the indwelling catheter in the proper or the common hepatic artery. These studies showed that dislocation of the indwelling catheter occurs at a relatively high rate—in 5.6-43.8% of patients [9,10,11,12,13,14]. The rate of hepatic arterial obstruction is also relatively high, ranging from 0% to 22.2% [9,10,11,12,13,14].

In comparison, data from our study showed lower rates: 2.2% (2/93) for catheter dislocation and 5.4% (5/93) for arterial obstruction. It follows from these results that the fixed-catheter-tip technique using n-butyl cyanoacrylate added to the microcoils is useful in preventing the complications of dislocation or hepatic arterial obstruction. Other complications related to the technique were only minor, such as movement of n-butyl cyanoacrylate and recanalization of the gastroduodenal artery. These complications resolved with careful observation of the patients alone or were easily corrected with simple interventional techniques. In the three patients with hepatic arterial obstruction, further hepatic arterial—infusion chemotherapy was successfully performed. As a result, in five (62.5%) of the eight patients with complications and in 90 (96.8%) of the entire 93 patients in whom an indwelling catheter was placed, planned hepatic arterial infusion chemotherapy could be performed without a problem. It can be concluded from the results of our study that fixation of the catheter tip to the gastroduodenal artery using a combination of microcoils and a mixture of n-butyl cyanoacrylate and iodized oil is useful and safe for catheter placement in hepatic arterial—infusion chemotherapy.

Theoretically, the fixed-catheter-tip technique can prevent dislocation of the indwelling catheter, which is one of the more frequent complications, because the catheter tip is tightly fixed in an arterial branch. However, a few cases of catheter dislocation have occurred [8]. In response, we added a mixture of n-butyl cyanoacrylate and iodized oil to the microcoils for a stronger fixation of the catheter tip. In our previous study [8], we found a significantly higher rate of catheter dislocation in patients in whom fixation of the catheter tip was performed without the mixture than in those in whom the mixture was used to strengthen fixation.

Hepatic arterial occlusion, another frequent complication, often interferes with effective hepatic arterial—infusion chemotherapy. The low frequency of hepatic arterial occlusion shown in our present study indicates that this problem also can be resolved using the catheter-fixation technique. According to Seki et al. [15], hepatic artery patency was statistically higher in a group of patients with port-catheter systems that had been implanted with the catheter tip fixed with microcoils alone or with n-butyl cyanoacrylate in addition to microcoils than in the group in whom the catheter tip had been placed in the proper or common hepatic artery without fixation. This finding leads us to speculate that a principal cause of hepatic arterial occlusion is thrombotic occlusion due to mechanical stimulation of the vascular endothelium of the common or proper hepatic artery, which results from movement of the unfixed tip of the percutaneously placed catheter [15]. Hence, development of methods to fix the distal tip of the indwelling catheter in the gastroduodenal artery to prevent movement of the catheter in the hepatic artery has decreased the rate of hepatic arterial occlusion.

Most researchers studying percutaneous port-catheter implantation using the fixed-catheter-tip technique have focused on catheter fixation with microcoils alone [15,16,17]. To our knowledge, no large study in the English-language literature has described the use of n-butyl cyanoacrylate in percutaneous catheter placement, with the exception of our previous article [8].

N-butyl cyanoacrylate is widely used as a permanent embolic agent, especially in intracerebral interventional radiology procedures such as the embolization of arteriovenous malformation [18, 19]. Adding iodized oil to the n-butyl cyanoacrylate permits the embolized vessel to be visualized on imaging. Also, the adhesion time can be adjusted according to the concentration of the mixed iodized oil. Thus, organ infarction, a potential complication caused by possible transarterial embolization of two peripheral arterial branches using n-butyl cyanoacrylate, can be prevented by hastening the adhesion time [7]. N-butyl cyanoacrylate has been used as a liquid acrylic adhesive material in the field of surgery. Our study shows that n-butyl cyanoacrylate is useful not only as an embolic agent but as an adhesive agent in the field of interventional radiology.


References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 

  1. Lorenz M, Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000;18:243 -254[Abstract/Free Full Text]
  2. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastasis. Lancet 1994;344:1255 -1260[Medline]
  3. Valeri A, Mini E, Tonelli P, et al. Intra-arterial hepatic chemotherapy with 5-fluorouracil and 5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer. Anticancer Res 1994;14:2215 -2220[Medline]
  4. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112 -1118[Abstract]
  5. Niederhuber JE, Ensminger WD. Surgical considerations in the management of hepatic neoplasia. Semin Oncol 1983;10:135 -147[Medline]
  6. Huk I, Entsheff P, Prager M, Schulz F, Polterauer P, Funovics J. Patency rate of implantable devices during long-term intraarterial chemotherapy. Angiology 1990;41:936 -941
  7. Arai Y, Inaba Y, Takeuchi Y. Interventional techniques for hepatic arterial infusion chemotherapy. In: Castaneda-Zuniga WR, ed. Interventional Radiology, 3rd ed. Baltimore: Williams & Wilkins, 1997:192 -205
  8. Yamagami T, Nakamura T, Yamazaki S, Iida S, Kato T, Nishimura T. Catheter-tip fixation of a percutaneously implanted port-catheter system to prevent dislocation. Eur Radiol 2002;12:443 -449[Medline]
  9. Wacker FK, Boese-Landgraf J, Wagner A, Albrecht D, Wolf K-J, Fobbe F. Minimally invasive catheter implantation for regional chemotherapy of the liver: a new percutaneous transsubclavian approach. Cardiovasc Intervent Radiol 1997;20:128 -132[Medline]
  10. Clouse ME, Ahmed R, Ryan RB, Oberfield RA, McCaffrey JA. Complications of long term transbrachial hepatic arterial infusion chemotherapy. AJR 1977;129:799 -803[Abstract]
  11. Oberfield RA, McCaffrey JA, Polio J, Clouse ME, Hamilton T. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 1979;44:414 -423[Medline]
  12. Herrmann KA, Waggershauser T, Sittek H, Reiser MF. Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheterport systems. Radiology 2000;215:294 -299[Abstract/Free Full Text]
  13. Germer CT, Boese-Landgraf J, Albrecht D, Wagner A, Wolf KJ, Buhr HJ. The totally implantable minimally invasive hepatic arterial catheter for intraarterial chemotherapy of unresectable liver metastasis in cases of dysfunction of arterial access devices [in German]. Chirurg 1996;67:458 -462[Medline]
  14. Strecker E-PK, Boos IBL, Ostheim-Dzerowycz W, Heber R, Vetter SC. Percutaneously implantable catheter-port system: preliminary technical results. Radiology 1997;202:574 -577[Abstract/Free Full Text]
  15. Seki H, Kimura M, Yoshimura N, Yamamoto S, Ozaki T, Sakai K. Hepatic arterial infusion chemotherapy using percutaneous catheter placement with an implantable port: assessment of factors affecting patency of the hepatic artery. Clin Radiology 1999;54:221 -227[Medline]
  16. Irie T. Intraarterial chemotherapy of liver metastases: implantation of a microcatheter-port system with use of modified catheter tip technique. J Vasc Interv Radiol 2001;12:1215 -1218[Medline]
  17. Shindoh N, Ozaki Y, Kyogoku S, Yamana D, Sumi Y, Katayama H. Stabilization of a percutaneously implanted port catheter system for hepatic artery chemotherapy infusion. Cardiovasc Intervent Radiol 1999;22:344 -347[Medline]
  18. Han MH, Seong SO, Kim HD, Chang KH, Yeon KM, Han MC. Craniofacial arteriovenous malformation: preoperative embolization with direct puncture and injection of n-butyl cyanoacrylate. Radiology 1999;211:661 -666[Abstract/Free Full Text]
  19. Debrun GM, Aletich V, Ausman JI, Charbel F, Dujovny M. Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 1997;40:112 -121[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
T. Yamagami, K. Terayama, R. Yoshimatsu, T. Matsumoto, H. Miura, and T. Nishimura
Use of N-Butyl Cyanoacrylate in Implantation of a Port-Catheter System for Hepatic Arterial Infusion Chemotherapy with the Fixed-Catheter-Tip Method: Is It Necessary?
Am. J. Roentgenol., November 1, 2008; 191(5): 1523 - 1529.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
A. Ganeshan, S. Upponi, L.-q. Hon, D. Warakaulle, and R. Uberoi
Hepatic arterial infusion of chemotherapy: the role of diagnostic and interventional radiology
Ann. Onc., May 1, 2008; 19(5): 847 - 851.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Iguchi, Y. Inaba, Y. Arai, H. Yamaura, Y. Sato, M. Miyazaki, H. Shimamoto, and T. Hayashi
Radiologic removal and replacement of port-catheter systems for hepatic arterial infusion chemotherapy.
Am. J. Roentgenol., December 1, 2006; 187(6): 1579 - 1584.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Yamagami, T. Kato, S. Iida, T. Hirota, and T. Nishimura
Management of End Hole in Placement of Port-Catheter System for Continuous Hepatic Arterial Infusion Chemotherapy Using the Fixed Catheter Tip Method
Am. J. Roentgenol., April 1, 2005; 184(4): 1332 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Tajima, K. Yoshimitsu, T. Kuroiwa, T. Ishibashi, H. Irie, H. Aibe, K. Shinozaki, A. Nishie, H. Yabuuchi, and H. Honda
Percutaneous Femoral Catheter Placement for Long-Term Chemotherapy Infusions: Preliminary Technical Results
Am. J. Roentgenol., March 1, 2005; 184(3): 906 - 914.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Yamagami, T. Kato, S. Iida, T. Hirota, and T. Nishimura
Efficacy of the Left Gastric Artery as a Route for Catheterization of the Right Gastric Artery
Am. J. Roentgenol., January 1, 2005; 184(1): 220 - 224.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. Yamagami, T. Kato, S. Iida, O. Tanaka, and T. Nishimura
Value of Transcatheter Arterial Embolization with Coils and n-Butyl Cyanoacrylate for Long-term Hepatic Arterial Infusion Chemotherapy
Radiology, March 1, 2004; 230(3): 792 - 802.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamagami, T.
Right arrow Articles by Nishimura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamagami, T.
Right arrow Articles by Nishimura, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS